Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Infodemiology

Date Submitted: Oct 13, 2024
Open Peer Review Period: Oct 18, 2024 - Dec 13, 2024
Date Accepted: May 19, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Exploring Pain on Social Media: Observational Study on Perceptions and Discussions of Chronic Pain Conditions

Valades MT, Fernandez-Lazaro CI, Lara-Abelenda FJ, Montero-Torres M, Cuberta I, Ortega MA, Alvarez-Mon M, Alvarez-Mon MA

Exploring Pain on Social Media: Observational Study on Perceptions and Discussions of Chronic Pain Conditions

JMIR Infodemiology 2025;5:e67473

DOI: 10.2196/67473

PMID: 40956980

PMCID: 12440231

"Exploring Pain in Social Media: A Study on Perceptions and Discussions of Chronic Pain Conditions”

  • Maria Teresa Valades; 
  • Cesar Ignacio Fernandez-Lazaro; 
  • Francisco Javier Lara-Abelenda; 
  • María Montero-Torres; 
  • Inés Cuberta; 
  • Miguel Angel Ortega; 
  • Melchor Alvarez-Mon; 
  • Miguel Angel Alvarez-Mon

ABSTRACT

Background:

Chronic pain, an unpleasant sensory and emotional experience lasting over six months, affects a large proportion of the global population and significantly impacts health and quality of life. Certain diseases cause chronic pain, resulting in a social and medical misunderstanding that intensity the patient’s emotional suffering. In recent years, the social media platform Twitter, now called “X,” has become a valuable resource for research and discussion on chronic pain, providing an accessible environment for communication and information exchange.

Objective:

To analyze content on Twitter related to fibromyalgia, headache, paraplegia, neuropathy, and multiple sclerosis, as well as characterize the profile of users involved in these conversations, identify prevalent topics, measure public perception, evaluate treatment efficacy, and detect discussions related to the most frequent non-medical issues.

Methods:

72,874 tweets in English and Spanish containing pre-specified keywords were collected between 2018 and 2022. A manual review was conducted on 2,500 tweets, and the larger subset was classified by machine learning methods. Subsequently, tweets related to chronic pain conditions were analyzed to examine their medical and non-medical content, types of X users, the origin of the disease, and the efficacy of treatments.

Results:

Of the total tweets collected, 55,451 (76,1%) were classifiable. The most active users were healthcare professionals and institutions. The primary perceived etiology was pharmacological, and higher treatment efficacy was noted in neuropathy, paraplegia, and multiple sclerosis. Regarding non-medical content, there were more tweets related to the definition and understanding of the disease.

Conclusions:

Social media platforms, such as X, are playing a crucial role in the dissemination of information on chronic pain. Discussions largely focus on the available treatments and the need to enhance public education, utilizing these platforms to correct misconceptions and provide better support to patients.


 Citation

Please cite as:

Valades MT, Fernandez-Lazaro CI, Lara-Abelenda FJ, Montero-Torres M, Cuberta I, Ortega MA, Alvarez-Mon M, Alvarez-Mon MA

Exploring Pain on Social Media: Observational Study on Perceptions and Discussions of Chronic Pain Conditions

JMIR Infodemiology 2025;5:e67473

DOI: 10.2196/67473

PMID: 40956980

PMCID: 12440231

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.